7 Thirteen kinds of Chinese medicine injections for acute exacerbation of chronic obstructive pulmonary disease: Protocol for a systematic review and network meta-analysis.

8 Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.

9 The Landscape of Chronic Pain: Broader Perspectives.

10 Hepatoprotective effects of chestnut (Castanea crenata) inner shell extract against chronic ethanol-induced oxidative stress in C57BL/6 mice.

11 Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients.

12 Physical activity and depression symptoms in women with chronic illness and the mediating role of health-related quality of life.

13 Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.

14 The Diocesan Structure of Rus during the Mongol-Tatar Invasion in 1237–1240 (according to the chronicles)

15 Biological Characterization and Inhibition of Streptococcus pyogenes ZUH1 Causing Chronic Cystitis by Crocus sativus Methanol Extract, Bee Honey Alone or in Combination with Antibiotics: An In Vitro Study

16 Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years

17 Dietary Meat Categories and Descriptions in Chronic Disease Research Are Substantively Different within and between Experimental and Observational Studies: A Systematic Review and Landscape Analysis

18 Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis

19 Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia

20 Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis

21 Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections.

22 Honey as an effective antimicrobial treatment for chronic wounds: is there a place for it in modern medicine?

23 Determination of renal blood flow with Doppler ultrasound and the hypertension prevalence and acid-base level in dogs with chronic renal failure

24 Targeting CD20 in chronic lymphocytic leukemia

25 Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

26 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

27 Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

28 Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

29 Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies

30 Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

31 Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

32 Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

33 Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection

34 Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

35 Invasive Aspergillus infections in hospitalized patients with chronic lung disease

36 Update on the management of chronic rhinosinusitis

37 Safety and efficacy of entecavir for the treatment of chronic hepatitis B

38 Current treatment of choice for chronic hepatitis C infection

39 New approaches in the management of chronic hepatitis B: role of tenofovir

40 Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

41 A review of spinal cord stimulation systems for chronic pain

42 Terminology of chronic pain: the need to "level the playing field"

43 Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

44 Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

45 Improving medication adherence of patients with chronic heart failure: challenges and solutions

46 Optimal treatment of chronic angina in patients with type 2 diabetes mellitus

47 Critical evaluation of ivabradine for the management of chronic stable angina

48 Targeting CD20 in chronic lymphocytic leukemia

49 Targeting CD20 in chronic lymphocytic leukemia

50 A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia

51 L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle

52 Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag

53 Gastric Siderosis and Ulceration from Intravenous Iron Supplementation Manifesting as Chronic Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature

54 Gastric Heterotopic Pancreas Presenting as Abdominal Pain with Acute and Chronic Pancreatitis in the Resected Specimen

55 A Case of Acquired Haemophilia A in a Patient with Chronic Myelomonocytic Leukaemia

56 Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

57 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

58 Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

59 Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

60 Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies

61 Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

62 Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B

63 Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

64 Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection

65 Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy

66 Successful Treatment of Sjögren’s Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid

67 Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

68 Invasive Aspergillus infections in hospitalized patients with chronic lung disease

69 Update on the management of chronic rhinosinusitis

70 Safety and efficacy of entecavir for the treatment of chronic hepatitis B

71 Current treatment of choice for chronic hepatitis C infection

72 New approaches in the management of chronic hepatitis B: role of tenofovir

73 Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

74 Urinary Uromodulin Levels and UMOD Variants in Black South Africans with Hypertension-Attributed Chronic Kidney Disease

75 Prevalence and Predictors of Chronic Kidney Disease in a Semiurban Community in Lagos

76 The Influence of Functional Endoscopic Sinus Surgery on Sleep Related Outcomes in Patients with Chronic Rhinosinusitis

77 Evaluation of Arterial Stiffness Using Pulse Wave Velocity and Augmentation Index in Patients with Chronic Venous Insufficiency

78 Determination of renal blood flow with Doppler ultrasound and the hypertension prevalence and acid-base level in dogs with chronic renal failure

79 A review of spinal cord stimulation systems for chronic pain

80 Terminology of chronic pain: the need to "level the playing field"

81 Laparoscopic repositioning of chronic gastric volvulus in a dog

82 Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

83 Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

84 Improving medication adherence of patients with chronic heart failure: challenges and solutions

85 Optimal treatment of chronic angina in patients with type 2 diabetes mellitus

86 Critical evaluation of ivabradine for the management of chronic stable angina

87 The application of IL-10 and TNF-α in expressed prostatic secretions and prostatic exosomal protein in urine in the diagnosis of patients with chronic prostatitis.

88 Variation in TMEM106B in chronic traumatic encephalopathy

89 Study of Evidences on Chronic Kidney Disease Due to Unknown Etiology Based on Environmental, Social, Economic and Health Patterns of Selected Population: A Case Study Done at Wilgamuwa Area

90 Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study.

91 Clinical correlates of depression chronicity among people living with HIV: What is the role of suicidal ideation?

92 Effectiveness and Cost-Effectiveness of Triple Therapy with Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from the Brazilian Public Health System Perspective

93 Correction: Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders (Arch Neuropsychiatry, (2015) 55, (330-336), 10.5152/npa.2017.19257)

94 Effect of scaling and root planing on serum interleukin-10 levels and glycemic control in chronic periodontitis and type 2 diabetes mellitus

95 Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.

96 Sandtray-Worldplay for people who experience chronic mental illness

97 Hoxa5 alleviates obesity-induced chronic inflammation by reducing ER stress and promoting M2 macrophage polarization in mouse adipose tissue.

98 Determination of genotoxic effects in hemodialysis patients with chronic kidney disease and the role of diabetes mellitus and other biochemical parameters.

99 Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker in Diabetes with Earlier Chronic Kidney Disease Stages

100 Prevalence and Disease Burden of Chronic Kidney Disease.

101 El ejercicio físico y su prescripción en pacientes con enfermedades crónicas degenerativas Physical exercise and its prescription in patients with chronic degenerative diseases

Keyword Connections

Journals

Research Groups

Bibliographies